101 related articles for article (PubMed ID: 17636471)
1. The 1040C/T polymorphism influencing thermal stability and activity of thrombin activatable fibrinolysis inhibitor is associated with risk for oral cancer.
Vairaktaris E; Yapijakis C; Nkenke E; Vassiliou S; Vylliotis A; Nixon AM; Derka S; Ragos V; Spyridonidou S; Tsigris C; Neukam FW; Patsouris E
Am J Hematol; 2007 Nov; 82(11):1010-2. PubMed ID: 17636471
[TBL] [Abstract][Full Text] [Related]
2. The interleukin-8 (-251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma.
Vairaktaris E; Yapijakis C; Serefoglou Z; Derka S; Vassiliou S; Nkenke E; Vylliotis A; Wiltfang J; Avgoustidis D; Critselis E; Neukam FW; Patsouris E
Eur J Surg Oncol; 2007 May; 33(4):504-7. PubMed ID: 17174061
[TBL] [Abstract][Full Text] [Related]
3. +1040 C/T polymorphism in coding region of thrombin-activatable fibrinolysis inhibitor gene and the risk of idiopathic recurrent fetal loss.
Pruner I; Djordjevic V; Miljic P; Kovac M; Antonijevic N; Rakicevic L; Radojkovic D
Blood Coagul Fibrinolysis; 2010 Oct; 21(7):679-82. PubMed ID: 20729722
[TBL] [Abstract][Full Text] [Related]
4. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer.
Vairaktaris E; Yapijakis C; Tsigris C; Vassiliou S; Derka S; Nkenke E; Spyridonidou S; Vylliotis A; Vorris E; Ragos V; Neukam FW; Patsouris E
Acta Oncol; 2007; 46(8):1097-102. PubMed ID: 17851834
[TBL] [Abstract][Full Text] [Related]
5. The effect of genetic variants in the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI-antigen levels, clot lysis time and the risk of venous thrombosis.
Martini CH; Brandts A; de Bruijne EL; van Hylckama Vlieg A; Leebeek FW; Lisman T; Rosendaal FR
Br J Haematol; 2006 Jul; 134(1):92-4. PubMed ID: 16803573
[TBL] [Abstract][Full Text] [Related]
6. The interleukin-10 (-1082A/G) polymorphism is strongly associated with increased risk for oral squamous cell carcinoma.
Vairaktaris E; Yapijakis C; Serefoglou Z; Derka S; Vassiliou S; Nkenke E; Vylliotis A; Spyridonidou S; Neukam FW; Schlegel KA; Patsouris E
Anticancer Res; 2008; 28(1A):309-14. PubMed ID: 18383862
[TBL] [Abstract][Full Text] [Related]
7. A metalloproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma.
Vairaktaris E; Vassiliou S; Nkenke E; Serefoglou Z; Derka S; Tsigris C; Vylliotis A; Yapijakis C; Neukam FW; Patsouris E
Eur J Surg Oncol; 2008 Apr; 34(4):450-5. PubMed ID: 17498910
[TBL] [Abstract][Full Text] [Related]
8. High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer.
Vairaktaris E; Serefoglou Z; Yapijakis C; Vylliotis A; Nkenke E; Derka S; Vassiliou S; Avgoustidis D; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(4B):2493-8. PubMed ID: 17695544
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis.
de Bruijne EL; Darwish Murad S; de Maat MP; Tanck MW; Haagsma EB; van Hoek B; Rosendaal FR; Janssen HL; Leebeek FW;
Thromb Haemost; 2007 Feb; 97(2):181-5. PubMed ID: 17264944
[TBL] [Abstract][Full Text] [Related]
10. Angiotensinogen polymorphism is associated with risk for malignancy but not for oral cancer.
Vairaktaris E; Yapijakis C; Vylliotis A; Derka S; Vassiliou S; Nkenke E; Serefoglou Z; Ragos V; Critselis E; Avgoustidis D; Neukam F; Patsouris E
Anticancer Res; 2008; 28(3A):1675-9. PubMed ID: 18630525
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer.
Vairaktaris E; Yapijakis C; Serefoglou Z; Vylliotis A; Ries J; Nkenke E; Wiltfang J; Derka S; Vassiliou S; Springer I; Kessler P; Neukam FW
Oral Oncol; 2006 Oct; 42(9):888-92. PubMed ID: 16730474
[TBL] [Abstract][Full Text] [Related]
12. Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer.
Vairaktaris E; Yapijakis C; Vasiliou S; Derka S; Nkenke E; Serefoglou Z; Vorris E; Vylliotis A; Ragos V; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(6B):4095-100. PubMed ID: 18225577
[TBL] [Abstract][Full Text] [Related]
13. Thrombin-activatable fibrinolysis inhibitor polymorphisms and recurrent pregnancy loss.
Masini S; Ticconi C; Gravina P; Tomassini M; Pietropolli A; Forte V; Federici G; Piccione E; Bernardini S
Fertil Steril; 2009 Aug; 92(2):694-702. PubMed ID: 18774564
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for oral cancer.
Ku KT; Wan L; Peng HC; Tsai MH; Tsai CH; Tsai FJ
Oral Oncol; 2005 May; 41(5):497-502. PubMed ID: 15878754
[TBL] [Abstract][Full Text] [Related]
15. [Study on the association of thrombin activatable fibrinolysis inhibitor and the Thr325Ile and Thr147Ala polymorphisms of its encoding gene CPB2 in patients with coronary heart disease].
Xu CW; Wang LL; Wu XB; Zhao JJ; Du YM; Jiang CY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):438-42. PubMed ID: 18683146
[TBL] [Abstract][Full Text] [Related]
16. The platelet glycoprotein Ibalpha VNTR polymorphism is associated with risk for oral cancer.
Vairaktaris E; Serefoglou ZC; Yapijakis C; Vassiliou S; Nkenke E; Avgoustidis D; Vylliotis A; Stathopoulos P; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(6B):4121-5. PubMed ID: 18225582
[TBL] [Abstract][Full Text] [Related]
17. Association of matrix metalloproteinase-1 (-1607 1G/2G) polymorphism with increased risk for oral squamous cell carcinoma.
Vairaktaris E; Yapijakis C; Derka S; Serefoglou Z; Vassiliou S; Nkenke E; Ragos V; Vylliotis A; Spyridonidou S; Tsigris C; Yannopoulos A; Tesseromatis C; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(1A):459-64. PubMed ID: 17352267
[TBL] [Abstract][Full Text] [Related]
18. Association of genotypes of thrombin-activatable fibrinolysis inhibitors with thrombotic microangiopathies--a pilot study.
Sucker C; Hetzel GR; Farokhzad F; Dahhan F; Schmitz M; Kurschat C; Grabensee B; Maruhn-Debowski B; Zotz R; Scharf R
Nephrol Dial Transplant; 2007 May; 22(5):1347-50. PubMed ID: 17327284
[TBL] [Abstract][Full Text] [Related]
19. Haplotypes of TAFI gene and the risk of cerebral venous thrombosis--a case-control study.
Orikaza CM; Morelli VM; Matos MF; Lourenço DM
Thromb Res; 2014 Jan; 133(1):120-4. PubMed ID: 24252537
[TBL] [Abstract][Full Text] [Related]
20. Increased risk for oral cancer is associated with coagulation factor XIII but not with factor XII.
Vairaktaris E; Vassiliou S; Yapijakis C; Spyridonidou S; Vylliotis A; Derka S; Nkenke E; Fourtounis G; Neukam FW; Patsouris E
Oncol Rep; 2007 Dec; 18(6):1537-43. PubMed ID: 17982641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
